Jun Gu
Impact in
- Geriatrics and Gerontology top 2%
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cell death mechanisms and regulation 9
- Cancer-related gene regulation 7
-
- Atrial Fibrillation Management and Outcomes 9
- Chemotherapy-induced cardiotoxicity and mitigation 8
- Co-authors
- Changqian Wang (12 shared papers)Jianguo Chen (8 shared papers)Yingbin Liu (25 shared papers)Wei Hu (6 shared papers)Jianan Pan (9 shared papers)Junfeng Zhang (9 shared papers)Fang Wang (6 shared papers)Ping Dong (14 shared papers)
- Journals
- Advanced Science (3 papers)Cell Research (3 papers)Frontiers in Cardiovascular Medicine (3 papers)Cancer Letters (3 papers)International Immunopharmacology (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Jun Gu
120 papers receiving 3.9k citations
Jun Gu's Hit Papers
Peers
Comparison fields: 5 of 138
- Geriatrics and Gerontology 115
- Cancer Research 505
- Cardiology and Cardiovascular Medicine 603
- Molecular Biology 1.7k
- Neurology 186
Countries citing papers authored by Jun Gu
This map shows the geographic impact of Jun Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Gu more than expected).
Fields of papers citing papers by Jun Gu
This network shows the impact of papers produced by Jun Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Gu. The network helps show where Jun Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 202 | |
| 2 | Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells Hit paper breakdown → | 2021 | 149 |
| 3 | 2009 | 142 | |
| 4 | 2010 | 137 | |
| 5 | 2004 | 107 | |
| 6 | 2011 | 102 | |
| 7 | 2019 | 95 | |
| 8 | 2007 | 88 | |
| 9 | 2012 | 87 | |
| 10 | 2018 | 85 | |
| 11 | 2013 | 82 | |
| 12 | 2016 | 80 | |
| 13 | 2011 | 79 | |
| 14 | 2010 | 77 | |
| 15 | 2016 | 74 | |
| 16 | 2017 | 74 | |
| 17 | 2011 | 68 | |
| 18 | 2015 | 67 | |
| 19 | 2011 | 67 | |
| 20 | 2014 | 63 |
About Jun Gu
Jun Gu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 126 papers that have together received 4.0k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (9 papers), Cell death mechanisms and regulation (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Autophagy in Disease and Therapy (7 papers), Cancer-related gene regulation (7 papers), Gallbladder and Bile Duct Disorders (6 papers), Calcium signaling and nucleotide metabolism (4 papers) and Flavonoids in Medical Research (4 papers). The work is most often cited by research in Geriatrics and Gerontology (115 citations), Cancer Research (505 citations), Cardiology and Cardiovascular Medicine (603 citations), Molecular Biology (1.7k citations) and Neurology (186 citations). Jun Gu has collaborated with scholars based in China, United States and France. Frequent co-authors include Changqian Wang, Jianguo Chen, Yingbin Liu, Wei Hu, Jianan Pan, Junfeng Zhang, Fang Wang, Ping Dong, Jianhua Lu and Xiangsong Wu. Their work appears in journals such as Advanced Science, Cell Research, Frontiers in Cardiovascular Medicine, Cancer Letters and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.